Suppr超能文献

新型头孢菌素对图卢兹地区淋病奈瑟菌菌株的体外活性研究。

Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.

作者信息

Prère M F, Lefèvre J C, Lareng M B

出版信息

Chemotherapy. 1981;27 Suppl 1:15-8. doi: 10.1159/000238023.

Abstract

The study was carried out with 50 strains of gonococci. Susceptibility to the antibiotics was determined by standard sensitivity test, by systematic test for beta-lactamase and by measurement of the MICs. The cephalosporins tested were: moxalactam, cefotaxime, ceftriaxone, cefotiam, cefoxitin, cefazolin and cephalothin. Their activities were also compared with other beta-lactams, namely penicillin and ampicillin. The efficacy in vitro of the cephalosporins: in the lead, ceftriaxone, remarkably active, with cefotaxime following very close, and then moxalactam with cefotiam a little behind, and finally all the other beta-lactams tested. The median MICs of the new cephalosporins (moxalactam, cefotaxime, ceftriaxone and cefotiam) were at least 10 times greater than those of the other beta-lactams tested. The MIC values observed with a resistant strain (penicillin, ampicillin; MIC 256 microgram/ml) never exceed the maximum values found with the 50 susceptible strains.

摘要

该研究使用了50株淋病奈瑟菌。通过标准敏感性试验、β-内酰胺酶系统检测以及最小抑菌浓度(MIC)测定来确定这些菌株对各种抗生素的敏感性。所检测的头孢菌素包括:拉氧头孢、头孢噻肟、头孢曲松、头孢替安、头孢西丁、头孢唑林和头孢噻吩。它们的活性还与其他β-内酰胺类药物(即青霉素和氨苄西林)进行了比较。头孢菌素的体外疗效:领先的是头孢曲松,活性显著,头孢噻肟紧随其后,然后是拉氧头孢,头孢替安稍落后,最后是所有其他检测的β-内酰胺类药物。新型头孢菌素(拉氧头孢、头孢噻肟、头孢曲松和头孢替安)的中位MIC至少比其他检测的β-内酰胺类药物高10倍。用一株耐药菌株(青霉素、氨苄西林;MIC为256微克/毫升)观察到的MIC值从未超过50株敏感菌株所发现的最大值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验